» Articles » PMID: 9792708

Structural Requirements for O-glycosylation of the Mouse Hepatitis Virus Membrane Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1998 Oct 29
PMID 9792708
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The mouse hepatitis virus (MHV) membrane (M) protein contains only O-linked oligosaccharides. We have used this protein as a model to study the structural requirements for O-glycosylation. We show that MHV M is modified by the addition of a single oligosaccharide side chain at the cluster of 4 hydroxylamino acids present at its extreme amino terminus and identified Thr at position 5 as the functional acceptor site. The hydroxylamino acid cluster, which is quite conserved among O-glycosylated coronavirus M proteins, is not in itself sufficient for O-glycosylation. Downstream amino acids are required to introduce a functional O-glycosylation site into a foreign protein. In a mutagenic analysis O-glycosylation was found to be sensitive to some particular changes but no unique sequence motif for O-glycosylation could be identified. Expression of mutant M proteins in cells revealed that substitution of any 1 residue was tolerated, conceivably due to the occurrence of multiple UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases (GalNAc transferases). Indeed, MHV M served as a substrate for GalNac-T1, -T2, and -T3, as was demonstrated using an in situ glycosylation assay based on the co-expression of endoplasmic reticulum-retained forms of the GalNAc transferases with endoplasmic reticulum-resident MHV M mutants. The GalNAc transferases were found to have largely overlapping, but distinct substrate specificities. The requirement for a threonine as acceptor rather than a serine residue and the requirement for a proline residue three positions downstream of the acceptor site were found to be distinctive features.

Citing Articles

Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10.

Lapierre L, Roland J, Manning E, Caldwell C, Glenn H, Vidalain P Cells. 2024; 13(2).

PMID: 38247817 PMC: 10814003. DOI: 10.3390/cells13020126.


Evolutionary Signals in Coronaviral Structural Proteins Suggest Possible Complex Mechanisms of Post-Translational Regulation in SARS-CoV-2 Virus.

Garza-Dominguez R, Torres-Quiroz F Viruses. 2022; 14(11).

PMID: 36366566 PMC: 9696223. DOI: 10.3390/v14112469.


Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.

Yadav R, Chaudhary J, Jain N, Kumar Chaudhary P, Khanra S, Dhamija P Cells. 2021; 10(4).

PMID: 33917481 PMC: 8067447. DOI: 10.3390/cells10040821.


Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.

Wang Y, Grunewald M, Perlman S Methods Mol Biol. 2020; 2203:1-29.

PMID: 32833200 PMC: 7682345. DOI: 10.1007/978-1-0716-0900-2_1.


Membrane binding proteins of coronaviruses.

Alsaadi E, Jones I Future Virol. 2020; 14(4):275-286.

PMID: 32201500 PMC: 7079996. DOI: 10.2217/fvl-2018-0144.